Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
Mosca
Lori
L
Appel
Lawrence J
LJ
Benjamin
Emelia J
EJ
Berra
Kathy
K
Chandra-Strobos
Nisha
N
Fabunmi
Rosalind P
RP
Grady
Deborah
D
Haan
Constance K
CK
Hayes
Sharonne N
SN
Judelson
Debra R
DR
Keenan
Nora L
NL
McBride
Patrick
P
Oparil
Suzanne
S
Ouyang
Pamela
P
Oz
Mehmet C
MC
Mendelsohn
Michael E
ME
Pasternak
Richard C
RC
Pinn
Vivian W
VW
Robertson
Rose Marie
RM
Schenck-Gustafsson
Karin
K
Sila
Cathy A
CA
Smith
Sidney C
SC
Sopko
George
G
Taylor
Anne L
AL
Walsh
Brian W
BW
Wenger
Nanette K
NK
Williams
Christine L
CL
D002317:Cardiovascular Agents / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D015897:Comorbidity; D000075202:Contraindications; D004032:Diet; D015914:Estrogen Replacement Therapy; D019317:Evidence-Based Medicine; D015444:Exercise; D005104:Expert Testimony; D005260:Female; D005544:Forecasting; D006292:Health Priorities; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D006973:Hypertension / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D008019:Life Style; D010353:Patient Education as Topic; D012307:Risk Factors; D016540:Smoking Cessation
D002317:Cardiovascular Agents